Agiliti - AGTI Stock Forecast, Price & News

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agiliti in the last twelve months. There are currently 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" AGTI shares.
View AGTI analyst ratings or view top-rated stocks.

7 Wall Street analysts have issued 1-year price objectives for Agiliti's shares. Their AGTI share price forecasts range from $18.00 to $28.00. On average, they predict the company's stock price to reach $21.00 in the next twelve months. This suggests a possible upside of 9.0% from the stock's current price.
View analysts price targets for AGTI or view top-rated stocks among Wall Street analysts.

Agiliti's stock was trading at $16.31 at the beginning of the year. Since then, AGTI stock has increased by 18.1% and is now trading at $19.26.
View the best growth stocks for 2023 here.

Agiliti saw a increase in short interest during the month of December. As of December 30th, there was short interest totaling 4,060,000 shares, an increase of 43.0% from the December 15th total of 2,840,000 shares. Based on an average daily trading volume, of 395,300 shares, the days-to-cover ratio is presently 10.3 days. Approximately 12.2% of the shares of the company are sold short.
View Agiliti's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 14th 2023.
View our AGTI earnings forecast.

Agiliti, Inc. (NYSE:AGTI) issued its quarterly earnings data on Thursday, November, 10th. The company reported $0.15 earnings per share for the quarter, missing analysts' consensus estimates of $0.16 by $0.01. The company earned $271.19 million during the quarter, compared to analysts' expectations of $274.68 million. Agiliti had a net margin of 3.26% and a trailing twelve-month return on equity of 12.09%.

Agiliti updated its FY 2022 earnings guidance on Saturday, December, 10th. The company provided earnings per share guidance of $0.83-$0.88 for the period, compared to the consensus EPS estimate of $0.89. The company issued revenue guidance of $1.11 billion-$1.12 billion, compared to the consensus revenue estimate of $1.16 billion.

(AGTI) raised $500 million in an initial public offering (IPO) on Friday, April 23rd 2021. The company issued 26,300,000 shares at a price of $18.00-$20.00 per share. BofA Securities, Goldman Sachs, Morgan Stanley, BMO Capital Markets, Citigroup, Jefferies and UBS Investment Bank served as the underwriters for the IPO and KeyBanc Capital Markets, Raymond James, MUFG, SMBC Nikko, Mischler Financial Group and Siebert Williams Shank were co-managers.

Agiliti trades on the New York Stock Exchange (NYSE) under the ticker symbol "AGTI."

Agiliti's stock is owned by a number of retail and institutional investors. Top institutional investors include State of Alaska Department of Revenue (0.02%), Yousif Capital Management LLC (0.02%), Natixis Advisors L.P. (0.01%), Comerica Bank (0.01%), Louisiana State Employees Retirement System (0.01%) and Fifth Third Bancorp (0.01%). Insiders that own company stock include Bettyann Bird, Gary L Gottlieb, James B Pekarek, John L Workman, Lee M Neumann, Matthew E Mccabe, Robert L Creviston, Scott A Christensen and Thomas J Leonard.
View institutional ownership trends.

Shares of AGTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AGTI stock can currently be purchased for approximately $19.26.

Agiliti (NYSE:AGTI) has a market capitalization of $2.57 billion and generates $1.04 billion in revenue each year. The company earns $24.01 million in net income (profit) each year or $0.26 on an earnings per share basis.

The company employs 5,000 workers across the globe.

The official website for the company is www.agilitihealth.com. The company can be reached via phone at (952) 893-3200 or via email at ir@agilitihealth.com.